Concepedia

Pau Cerdà

PC

10

Publications

248

Citations

10

H-Index

2019

Active since

Affiliations

Institut d'Investigació Biomédica de Bellvitge(Current)

Bellvitge University Hospital

Universitat de Barcelona

Universitat Internacional de Catalunya

Institut Català d'Oncologia

Pau Cerdà is an author at Institut d'Investigació Biomédica de Bellvitge specializing in medicine, pathology, and scleroderma.

ORCID

Top concepts

Publications per year

2019–2023

10

Publications

10

PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1

Adriana Iriarte, Pau Cerdà, José María Mora et al. · Cells · 2019 · 49 citations · Full text

, , +15

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

Manuel Rubio‐Rivas, Mar Ronda, Ariadna Padullés et al. · International Journal of Infectious Diseases · 2020 · 43 citations · Full text

, , +5

Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings

José María Mora‐Luján, Adriana Iriarte, Esther Alba et al. · Journal of Clinical Medicine · 2019 · 34 citations · Full text

Gender differences in hereditary hemorrhagic telangiectasia severity

José María Mora‐Luján, Adriana Iriarte, Esther Alba et al. · Orphanet Journal of Rare Diseases · 2020 · 29 citations · Full text

New genetic drivers in hemorrhagic hereditary telangiectasia

Pau Cerdà, Sandra D. Castillo, Cinthia Aguilera et al. · European Journal of Internal Medicine · 2023 · 21 citations · Full text

Rows per page

1–5 of 10